BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38464582)

  • 1. Kayser-Fleischer rings: The pathognomonic for Wilson's disease.
    Singh P; Subedi B; Mahato D; Karn M
    Clin Case Rep; 2024 Mar; 12(3):e8642. PubMed ID: 38464582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
    Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
    J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kayser-Fleischer-like rings in patients without Wilson's disease.
    Frommer D; Morris J; Sherlock S; Abrams J; Newman S
    Gastroenterology; 1977 Jun; 72(6):1331-5. PubMed ID: 558126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.
    Krstić D; Antonijević J; Špirić Ž
    Vojnosanit Pregl; 2014 Dec; 71(12):1155-8. PubMed ID: 25639007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings.
    Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G
    Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson's Disease.
    Dong Y; Wang RM; Yang GM; Yu H; Xu WQ; Xie JJ; Zhang Y; Chen YC; Ni W; Wu ZY
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):590-596. PubMed ID: 32485301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings.
    Ross ME; Jacobson IM; Dienstag JL; Martin JB
    Ann Neurol; 1985 Apr; 17(4):411-3. PubMed ID: 4004163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ophthalmologic manifestations of Wilson's disease.
    Wiebers DO; Hollenhorst RW; Goldstein NP
    Mayo Clin Proc; 1977 Jul; 52(7):409-16. PubMed ID: 875462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease with hepatic presentation in childhood.
    Karim MB; Rahman MM; Islam MS
    Mymensingh Med J; 2007 Jan; 16(1):29-32. PubMed ID: 17344776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wilson's disease or hepatolenticular degeneration].
    Mensing B; Nowak A; Zweifel S; Terracciano L; Bernsmeier C; Filipowicz Sinnreich M
    Ther Umsch; 2018 Nov; 75(4):241-248. PubMed ID: 30468117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo confocal microstructural analysis of corneas presenting Kayser-Fleischer rings in patients with Wilson's disease.
    Grupchev DI; Radeva MN; Georgieva M; Grupcheva CN
    Arq Bras Oftalmol; 2018 Apr; 81(2):137-143. PubMed ID: 29846416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Unusual Presentation of Wilson's Disease.
    Kanitkar S; Borle A; Ahlawat M; Ande SP; Raut S
    Cureus; 2024 Apr; 16(4):e58407. PubMed ID: 38756326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Wilson's disease: an experience over three decades.
    Gow PJ; Smallwood RA; Angus PW; Smith AL; Wall AJ; Sewell RB
    Gut; 2000 Mar; 46(3):415-9. PubMed ID: 10673307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration). A follow-up study.
    Lössner A; Lössner J; Bachmann H; Zotter J
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(2):152-5. PubMed ID: 3949188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease.
    Esmaeli B; Burnstine MA; Martonyi CL; Sugar A; Johnson V; Brewer GJ
    Cornea; 1996 Nov; 15(6):582-8. PubMed ID: 8899270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson's disease in patients presenting with liver disease: a diagnostic challenge.
    Steindl P; Ferenci P; Dienes HP; Grimm G; Pabinger I; Madl C; Maier-Dobersberger T; Herneth A; Dragosics B; Meryn S; Knoflach P; Granditsch G; Gangl A
    Gastroenterology; 1997 Jul; 113(1):212-8. PubMed ID: 9207280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Prevalence of Wilson's Diseases with Low Prevalence of Kayser-Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh.
    Choudhury N; Quraishi SB; Atiqullah A; Khan MSI; Al Mahtab M; Akbar SM
    Euroasian J Hepatogastroenterol; 2019; 9(2):67-70. PubMed ID: 32117693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.